L
L. LuAnn Minich
Researcher at University of Utah
Publications - 185
Citations - 7638
L. LuAnn Minich is an academic researcher from University of Utah. The author has contributed to research in topics: Kawasaki disease & Internal medicine. The author has an hindex of 42, co-authored 171 publications receiving 6608 citations. Previous affiliations of L. LuAnn Minich include University of Michigan & Primary Children's Hospital.
Papers
More filters
Journal ArticleDOI
Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle Lesions
Richard G. Ohye,Lynn A. Sleeper,Lynn Mahony,Jane W. Newburger,Gail D. Pearson,Minmin Lu,Caren S. Goldberg,Sarah Tabbutt,Peter C. Frommelt,Nancy S. Ghanayem,Peter C. Laussen,John F. Rhodes,John F. Rhodes,John F. Rhodes,Alan B. Lewis,Seema Mital,Chitra Ravishankar,Ismee A. Williams,Carolyn Dunbar-Masterson,Andrew M. Atz,Steven D. Colan,L. LuAnn Minich,Christian Pizarro,Kirk R. Kanter,James Jaggers,James Jaggers,James Jaggers,Jeffrey P. Jacobs,Catherine D. Krawczeski,Nancy A. Pike,Brian W. McCrindle,Lisa Virzi,J. William Gaynor +32 more
TL;DR: In children undergoing the Norwood procedure, transplantation-free survival at 12 months was better with the RVPA shunt than with the MBT shunt, and the rate of nonfatal serious adverse events at the age of 12 months were similar in the two groups.
Journal ArticleDOI
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease
Jane W. Newburger,Lynn A. Sleeper,Brian W. McCrindle,L. LuAnn Minich,Welton M. Gersony,Victoria L. Vetter,Andrew M. Atz,Jennifer S. Li,Masato Takahashi,Annette L. Baker,Steven D. Colan,Paul Mitchell,Gloria L. Klein,Robert P. Sundel +13 more
TL;DR: The data do not provide support for the addition of a single pulsed dose of intravenous methylprednisolone to conventional intravenous immune globulin therapy for the routine primary treatment of children with Kawasaki disease.
Journal ArticleDOI
Coronary Artery Involvement in Children With Kawasaki Disease Risk Factors From Analysis of Serial Normalized Measurements
Brian W. McCrindle,Jennifer S. Li,L. LuAnn Minich,Steven D. Colan,Andrew M. Atz,Masato Takahashi,Victoria L. Vetter,Welton M. Gersony,Paul Mitchell,Jane W. Newburger +9 more
TL;DR: Analyses of serial normalized coronary artery measurements in optimally treated Kawasaki disease patients demonstrated that for most patients, measurements are greatest at baseline and subsequently diminish; baseline measurements appear to be good predictors of involvement during early follow-up.
Journal ArticleDOI
Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial.
Nancy S. Ghanayem,Kerstin Allen,Sarah Tabbutt,Andrew M. Atz,Martha L. Clabby,David S. Cooper,Pirooz Eghtesady,Peter C. Frommelt,Peter J. Gruber,Kevin D. Hill,Jonathan R. Kaltman,Peter C. Laussen,Alan B. Lewis,Karen J Lurito,L. LuAnn Minich,Richard G. Ohye,Julie V. Schonbeck,Steven M. Schwartz,Rakesh K. Singh,Caren S. Goldberg +19 more
TL;DR: Avoiding preterm delivery when possible and close surveillance after Norwood hospitalization for infants with identified risk factors may reduce interstage mortality, which remains high at 12% and is increased with the MBTS compared with the RVPAS if postoperative AVVR is absent or mild.
Journal ArticleDOI
Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin Resistance
Lynn A. Sleeper,L. LuAnn Minich,Brian M. McCrindle,Jennifer S. Li,Wilbert H. Mason,Steven D. Colan,Andrew M. Atz,Beth F. Printz,Annette L. Baker,Victoria L. Vetter,Jane W. Newburger +10 more
TL;DR: Primary steroid therapy did not improve coronary outcomes in patients prospectively classified as being at high-risk for IVIG resistance, and risk-scoring systems from Japan have good specificity but low sensitivity for predictingIVIG resistance in a North American cohort.